Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
Author(s) -
Silvio E. Inzucchi,
Mikhail Kosiborod,
David Fitchett,
Christoph Wanner,
Uwe Hehnke,
Stefan Kaspers,
Jyothis T. George,
Bernard Zinman
Publication year - 2018
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.035759
Subject(s) - medicine , empagliflozin , glycemic , diabetes mellitus , type 2 diabetes , cardiology , intensive care medicine , insulin , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom